Method for inactivating bocavirus

Through the combination of titanium dioxide magnetic microspheres and ultraviolet rays, the problem of Boca virus removal in blood products is solved, efficient removal rate and protection of raw plasma is achieved, and a low-cost and easy-to-use solution is provided.

CN119015453APending Publication Date: 2024-11-26GUANGDONG INST FOR DRUG CONTROL (GUANGDONG INST FOR DRUG QUALITY GUANGDONG PORT DRUG CONTROL INST)
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411386085.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-30
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art cannot effectively remove Boca virus in blood products, and common disinfection methods will damage beneficial components and affect the medicinal value.

Method used

Using the method of combining titanium dioxide magnetic microspheres with ultraviolet rays, pulse flow contact is carried out in a tube reactor to remove Boca virus in blood products, avoiding pH adjustment and chemical addition of raw plasma.

Benefits of technology

It has achieved efficient inactivation of Boca virus, increased the removal rate by 3-5 logarithmic orders, maintained the component integrity of raw plasma, simple operation, low cost, and reduced application risks.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015453A_ABST
    Figure CN119015453A_ABST
Patent Text Reader

Abstract

The invention discloses a bocavirus inactivation method which comprises the following step: in the presence of ultraviolet rays, a bocavirus-containing solution is in flowing contact with titanium dioxide magnetic microspheres to inactivate bocavirus. The titanium dioxide magnetic microspheres can be used as a catalyst to realize continuous and efficient inactivation of bocavirus in a blood product in combination with ultraviolet rays, and the catalyst prepared by the invention can improve the parvovirus load removal rate by 3-5 logarithmic levels (log), that is, the parvovirus load in raw material plasma can be completely removed and inactivated when the parvovirus load in the raw material plasma does not exceed 10 < 5 > Copies / mL. In addition, the method for inactivating the bocavirus by combining the catalyst with ultraviolet rays does not need to adjust pH and add soluble chemical substances, so that the components of raw material plasma are not influenced, the application cost is low, the operation is simple, convenient and feasible, and the method has a wide application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of virus treatment, and in particular relates to a method for inactivating boca virus. Background Art

[0002] With the improvement of medical standards and the rapid development of the biopharmaceutical industry in recent years, the consumption of blood products and raw plasma has increased dramatically. Due to the possibility of potential contamination of viruses in various biological products and blood products, the overall risk of the blood products market is also on the rise. Human Bocavirus (HBoV) is a new type of linear single-stranded DNA virus discovered in recent years. It can cause serious respiratory and digestive system infections in children and people with low immunity. It has been frequently detected in blood products in many countries in the United States, Europe and Asia. The commonly used disinfection methods such as heating, S / D, and low pH in the production process of blood products cannot achieve effective inactivation, and its contamination problem has attracted great attention from the biopharmaceutical industry. At present, there are no standard detection methods and load limits for HBoV in raw plasma and blood products at home and abroad, and there is no systematic study on the distribution status and medication risks, and related manufacturers do not have quality control standards.

[0003] To solve this problem, the existing methods mainly include physical methods (such as patent CN106823541A and patent CN116251476A) and chemical methods (such as patent CN110974984A and patent CN116407652A), but the above methods often require adjustments to the raw materials of blood products, such as adding non-ionic surfactants and azole compounds, or adjusting the solution pH to 3.5-4.5. Although chemical methods can effectively kill related viruses in the raw plasma of blood products, they also bring potential threats to some of the beneficial components, resulting in a reduction in medicinal value. Therefore, it is necessary to develop a method for inactivating parvovirus that does not affect the raw plasma and is convenient and efficient. Summary of the invention

[0004] In order to overcome the problems existing in the above-mentioned prior art, the object of the present invention is to provide a method for inactivating Boca virus.

[0005] In order to achieve the above object, the technical solution adopted by the present invention is:

[0006] The invention provides a method for inactivating boca virus, comprising the following steps: in the presence of ultraviolet rays, a solution containing boca virus is brought into flow contact with titanium dioxide magnetic microspheres to inactivate the boca virus.

[0007] Preferably, the titanium dioxide magnetic microspheres are silicon dioxide-coated ferroferric oxide magnetic microspheres; the silicon dioxide-coated ferroferric oxide magnetic microspheres are prepared by a preparation method comprising the following steps: firstly, adding ferroferric oxide particles to a titanium sulfate solution, and then adding sodium hydroxide to react, so as to prepare the titanium dioxide magnetic microspheres.

[0008] More preferably, the concentration of the titanium sulfate solution is 0.1-0.5 mol / L.

[0009] More preferably, the particle size of the ferrosoferric oxide particles is 0.5-1.0 mm.

[0010] More preferably, the titanium dioxide magnetic microspheres are prepared by a preparation method comprising the following steps: firstly, adding ferrosoferric oxide particles into a titanium sulfate solution, then slowly adding a sodium hydroxide solution, and reacting under stirring to prepare the titanium dioxide magnetic microspheres.

[0011] Further preferably, when the surface of the black Fe3O4 particles becomes obviously white, the addition of NaOH is stopped, and stirring is continued for 3-5 minutes; and NaOH is continued to be added until the number of white particles no longer increases.

[0012] Further preferably, the concentration of the sodium hydroxide is 0.5-0.8 mol / L.

[0013] Preferably, the volume ratio of the solution containing bocavirus to all titanium dioxide magnetic microspheres is (2-5):1.

[0014] Preferably, the solution containing bocavirus is a blood product containing bocavirus.

[0015] Preferably, the wavelength of the ultraviolet light is 200-300 nm.

[0016] Preferably, the radiation dose of the ultraviolet light to the solution containing bocavirus is 5-20 J·cm -2 The light intensity of the ultraviolet light is 10-20w / m 2 .

[0017] Preferably, pulsed pneumatic conveying of the titanium dioxide magnetic microspheres is adopted to cause a pulsed flow of the titanium dioxide magnetic microspheres.

[0018] Titanium dioxide magnetic microspheres combined with pulse flow treatment are used to treat a solution containing bocavirus. On the one hand, micro-magnetization can increase the specific gravity of titanium dioxide particles and control the titanium dioxide magnetic microspheres to complete the deposition process faster under the pulse state. On the other hand, micro-magnetization can make the titanium dioxide particles have mutual attraction, thus avoiding the loss and leakage of titanium dioxide magnetic microspheres.

[0019] More preferably, the expansion degree of the titanium dioxide magnetic microspheres is 60%-80%.

[0020] Assuming that the volume of the magnetic bead layer is V1 when it is in a static state, when it flows in the reverse direction from bottom to top, the gap between the magnetic bead layer becomes slightly larger due to the fluid resistance, and the apparent volume of the layer also increases to V2, V2>V1, which is called the expansion of the magnetic bead layer in this patent, (V2-V1) / V1×100%=expansion degree.

[0021] More preferably, the inactivation of boca virus is carried out in a tubular reactor, which includes a reaction tube body and a plurality of titanium dioxide magnetic microspheres, and specifically includes the following steps: the solution containing boca virus flows through the reaction tube body from bottom to top, the titanium dioxide magnetic microspheres flow in a pulse and reciprocate up and down in the reaction tube body, the solution containing boca virus contacts the plurality of titanium dioxide magnetic microspheres, and the boca virus is inactivated in the presence of ultraviolet rays.

[0022] Further preferably, the tubular reactor further comprises a pulse pump, and the pulse pump is arranged at the bottom of the tubular reactor.

[0023] Further preferably, the tubular reactor also includes an inner rod and a high-pressure mercury lamp, the inner rod is a glass tube, the inner rod is placed in the reaction tube body, the reaction tube body and the inner rod are fixed under the same axis, and the solution containing the boca virus flows through the cavity between the reaction tube body and the inner rod.

[0024] More preferably, the high pressure mercury lamp is arranged inside the inner rod.

[0025] Further preferably, the reaction tube body is a quartz glass tube.

[0026] Further preferably, the length of the reaction tube is 1-2 m.

[0027] More preferably, the inner diameter of the reaction tube is 0.5-2 m.

[0028] The beneficial effects of the present invention are:

[0029] (1) The present invention provides a method for inactivating bocavirus. The titanium dioxide magnetic microspheres can be used as a catalyst in combination with ultraviolet rays to achieve continuous and efficient inactivation of bocavirus in blood products. The catalyst prepared by the present invention can increase the removal rate of parvovirus load by 3-5 logarithmic levels (log), that is, the parvovirus load in the raw plasma does not exceed 10 5 Copies / mL can be completely removed and inactivated. In addition, the catalyst combined with ultraviolet light inactivation method of Bocavirus does not need to adjust pH and add soluble chemicals, so it does not affect the components of raw plasma, has low application cost, is simple and easy to operate, and has broad application prospects.

[0030] (2) The method for inactivating boca virus of the present invention uses a pulse pump to pulse-transfer plasma and titanium dioxide magnetic microspheres. The process is simple, and the titanium dioxide magnetic microspheres in the maximum expansion state return to the static state. The titanium dioxide magnetic microspheres perform up and down reciprocating motion in the reaction tube body for pulse-transfer, which can avoid the loss and leakage of the titanium dioxide magnetic microspheres. In addition, the raw plasma containing boca virus contacts with multiple titanium dioxide magnetic microspheres in a reciprocating flow, thereby enhancing the catalytic efficiency. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 Schematic diagram of a continuous flow casing treatment device; a is a pulse flow state, and b is a pulse static state;

[0032] 1-Quartz glass tube inner sleeve, 2-Titanium dioxide magnetic microspheres, 3-High pressure mercury lamp. DETAILED DESCRIPTION

[0033] The present invention is further described in detail below through specific examples. The raw materials used in the following examples, unless otherwise specified, can be obtained from conventional commercial sources or prepared and separated by simple synthesis; the processes used, unless otherwise specified, are conventional processes in the art.

[0034] Example 1

[0035] This embodiment provides a method for inactivating Boca virus, and the method is as follows:

[0036] 1. Preparation of titanium dioxide magnetic microspheres

[0037] Magnetic Fe3O4 microparticles (particle size 0.5-1.0 mm) were added into 0.4 mol·L -1 Ti(SO4)2 solution; then slowly add 0.6 mol·L -1 Add NaOH, and stop adding NaOH when the surface of the black Fe3O4 particles appears obviously white. Continue stirring for 3-5 minutes; continue to add NaOH until the number of white particles stops increasing; the main reaction in this process is: Ti(SO4)2+4NaOH→TiO2↓+2Na2SO4, and the generated TiO2 is evenly loaded on the surface of the magnetic Fe3O4 microparticles to obtain silicon dioxide-coated ferroferric oxide magnetic microspheres, namely titanium dioxide magnetic microspheres.

[0038] 2. Preparation of continuous flow casing treatment device:

[0039] Figure 1This is a schematic diagram of a continuous flow sleeve-type treatment device. A quartz glass inner sleeve (1m long, 80mm in diameter) is placed in another quartz glass tube (100mm in diameter) and fixed coaxially; a UV254 high-pressure mercury lamp is placed in the inner core of the quartz glass inner sleeve; the prepared titanium dioxide magnetic microspheres are loaded into the annular cavity area between the two quartz glass tubes, with a filling degree of 1 / 4 and a height of 250mm; a pulse pump is connected to the bottom of the sleeve to obtain a continuous flow sleeve-type treatment device.

[0040] 3. Inactivation of Bocavirus in blood products

[0041] (1) Human plasma, the raw material of a certain intravenous immunoglobulin production enterprise, was used as the treatment object and treated by the above-mentioned continuous flow tube-type treatment device. The UV254 high-pressure mercury lamp was set to an ultraviolet wavelength of 254 nm, and the ultraviolet radiation dose to the solution containing boca virus was 10 J·cm -2 The light intensity of the ultraviolet light is 10-20w / m 2 , a pulse pump is used to control the raw plasma to flow from bottom to top in the annular cavity area.

[0042] (2) The working performance of the pulse pump is adjusted, and the titanium dioxide magnetic microspheres are conveyed by pulsed pneumatic conveying, so that the pulsating flow generated by the pulsed pump can just make the titanium dioxide magnetic microspheres expand to a sufficient degree (after expansion, the height of the titanium dioxide magnetic microspheres rises to 450 mm, (450-250) / 250=80%, that is, the maximum expansion degree is 80%); the pulse period should be just enough to make the titanium dioxide magnetic microspheres in the maximum expansion state return to a static state; the titanium dioxide magnetic microspheres reciprocate up and down in the reaction tube body, and the raw plasma containing the boca virus contacts the multiple titanium dioxide magnetic microspheres, and the boca virus is inactivated in the presence of ultraviolet rays.

[0043] (3) Using the above process, the efficiency of single-tube blood product processing is about 4 L / min. After treatment, the standard PCR method can be used to reduce the detection limit of the instrument, and the removal rate is maintained at 3.5 logarithmic levels, reducing the risk of Bocavirus contamination to negligible.

[0044] The process conditions adopted by the method of the present invention are mild, and no pH adjustment or additional chemical solvent addition is required, and no subsequent neutralization or removal of added chemicals and by-products is required; no toxic waste or wastewater is generated during the removal process; the carrier quartz glass tube is low in cost, easy to process, and convenient for practical application; only a pulse pump is required to pulse-transport plasma or blood products, and no additional pressurization of plasma and products is required, which is highly efficient and energy-saving; the combination is flexible and can be applied to both small-volume enterprises and large-volume enterprises.

[0045] The method of the present invention uses titanium dioxide magnetic microspheres combined with pulse flow to treat a solution containing bocavirus. On the one hand, micro-magnetization can increase the specific gravity of titanium dioxide particles and control the titanium dioxide magnetic microspheres to complete the deposition process faster under the pulse state. On the other hand, micro-magnetization can make the titanium dioxide particles have attraction between each other, thereby avoiding the loss and leakage of titanium dioxide magnetic microspheres.

[0046] The experimental results show that under the same conditions, the method of the present invention can increase the removal rate of Bocavirus load by 3-5 logarithmic levels without causing any negative impact on the quality of raw plasma and blood products.

[0047] The above is a preferred embodiment of the present invention. It should be pointed out that a person skilled in the art can make several improvements and modifications without departing from the principle of the present invention. These improvements and modifications are also considered to be within the scope of protection of the present invention.

Claims

1. A method for inactivating Boca virus, characterized in that: The method comprises the following steps: in the presence of ultraviolet rays, a solution containing boca virus is brought into flow contact with titanium dioxide magnetic microspheres to inactivate the boca virus.

2. The method for inactivating Boca virus according to claim 1, characterized in that: The titanium dioxide magnetic microspheres are silicon dioxide-coated ferroferric oxide magnetic microspheres; the silicon dioxide-coated ferroferric oxide magnetic microspheres are prepared by a preparation method comprising the following steps: firstly, ferroferric oxide particles are added to a titanium sulfate solution, and then sodium hydroxide is added for reaction to prepare the titanium dioxide magnetic microspheres.

3. The method for inactivating Boca virus according to claim 2, characterized in that: The particle size of the ferrosoferric oxide particles is 0.5-1.0 mm.

4. The method for inactivating Boca virus according to claim 1, characterized in that: The volume ratio of the solution containing bocavirus to all titanium dioxide magnetic microspheres is (3-5):

1.

5. The method for inactivating Boca virus according to claim 1, characterized in that: The solution containing bocavirus is a blood product containing bocavirus.

6. The method for inactivating Boca virus according to claim 1, characterized in that: The wavelength of the ultraviolet rays is 200-300nm.

7. The method for inactivating Boca virus according to claim 6, characterized in that: The radiation dose of the ultraviolet light to the solution containing bocavirus is 5-20 J·cm -2 The light intensity of the ultraviolet light is 10-20w / m 2 .

8. The method for inactivating Bocavirus according to any one of claims 1 to 7, characterized in that: The titanium dioxide magnetic microspheres are conveyed by pulsed pneumatic force, so that the titanium dioxide magnetic microspheres flow in a pulsed manner.

9. The method for inactivating Boca virus according to claim 8, characterized in that: The expansion degree of the titanium dioxide magnetic microspheres is 60%-80%.

10. The method for inactivating Boca virus according to claim 8, characterized in that: The inactivation of Bocavirus is carried out in a tubular reactor; And / or, the tubular reactor comprises a reaction tube body and titanium dioxide magnetic microspheres; And / or, the specific method for inactivating boca virus comprises the following steps: the liquid containing boca virus flows through the reaction tube from bottom to top, the titanium dioxide magnetic microspheres flow in a pulse and reciprocate up and down in the reaction tube, the liquid containing boca virus contacts the titanium dioxide magnetic microspheres, and the boca virus is inactivated in the presence of ultraviolet rays.

Citation Information

Patent Citations

  • Method for purifying blood and blood products

    CN101273996A

  • In-vivo drug analysis method combining magnetic solid-phase extraction and rapid in-situ derivatization

    CN114594170A

  • Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same

    CN1764602A

  • Solar photocatalytic organic waste water treating device

    CN2649577Y

  • Method for lowering infectivity titer of virus using photocatalyst

    JP1996023970A